441 related articles for article (PubMed ID: 29224805)
21. Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
Kang M; Zhou P; Li G; Yan H; Feng G; Liu M; Zhu J; Wang R
Oncotarget; 2017 Sep; 8(41):70586-70594. PubMed ID: 29050304
[TBL] [Abstract][Full Text] [Related]
22. Extent of paranasal sinus involvement and its prognostic value in nasopharyngeal carcinoma: Proposed modification in the current UICC/AJCC staging system.
Wang XY; Zhu SY; Wu WJ; Li HJ; Li J; Lin XF; Li L; Liu LZ
Radiother Oncol; 2021 Jul; 160():221-227. PubMed ID: 33984350
[TBL] [Abstract][Full Text] [Related]
23. Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era.
Tang LL; Chen YP; Mao YP; Wang ZX; Guo R; Chen L; Tian L; Lin AH; Li L; Sun Y; Ma J
J Natl Compr Canc Netw; 2017 Jul; 15(7):913-919. PubMed ID: 28687579
[No Abstract] [Full Text] [Related]
24. The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity-modulated radiotherapy era.
Tang LL; Liang SB; Huang CL; Zhang F; Xu C; Mao YP; Tian L; Lin AH; Li L; Sun Y; Ma J
Cancer Med; 2019 May; 8(5):2213-2222. PubMed ID: 30950240
[TBL] [Abstract][Full Text] [Related]
25. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
[TBL] [Abstract][Full Text] [Related]
26. Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis.
Zhao W; Lei H; Zhu X; Li L; Qu S; Liang X
Oncotarget; 2016 Dec; 7(52):86914-86925. PubMed ID: 27894100
[TBL] [Abstract][Full Text] [Related]
27. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?
Guo R; Sun Y; Yu XL; Yin WJ; Li WF; Chen YY; Mao YP; Liu LZ; Li L; Lin AH; Ma J
Radiother Oncol; 2012 Sep; 104(3):294-9. PubMed ID: 22998947
[TBL] [Abstract][Full Text] [Related]
28. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
[TBL] [Abstract][Full Text] [Related]
29. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
Pan JJ; Ng WT; Zong JF; Lee SW; Choi HC; Chan LL; Lin SJ; Guo QJ; Sze HC; Chen YB; Xiao YP; Kan WK; O'Sullivan B; Xu W; Le QT; Glastonbury CM; Colevas AD; Weber RS; Lydiatt W; Shah JP; Lee AW
Cancer; 2016 Nov; 122(21):3307-3315. PubMed ID: 27434142
[TBL] [Abstract][Full Text] [Related]
30. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
31. A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.
He Y; Zhou Q; Shen L; Zhao Y; Lei M; Wei R; Shen L; Cao S
Radiat Oncol; 2015 Apr; 10():89. PubMed ID: 25881159
[TBL] [Abstract][Full Text] [Related]
32. Suggestions for lymph node classification of UICC/AJCC staging system: a retrospective study based on 1197 nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Guo Q; Pan J; Zong J; Zheng W; Zhang C; Tang L; Chen B; Cui X; Xiao Y; Chen Y; Lin S
Medicine (Baltimore); 2015 May; 94(20):e808. PubMed ID: 25997052
[TBL] [Abstract][Full Text] [Related]
33. Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up.
Wu LR; Zhang XM; Xie XD; Lu Y; Wu JF; He X
Oral Oncol; 2019 Nov; 98():141-146. PubMed ID: 31586896
[TBL] [Abstract][Full Text] [Related]
34. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
Luo Y; Gao Y; Yang G; Lang J
Biomed Res Int; 2016; 2016():4398498. PubMed ID: 27195286
[TBL] [Abstract][Full Text] [Related]
35. Validation and suggestion of eighth T classifications of the UICC/AJCC staging system for nasopharyngeal carcinoma patients: a retrospective analysis.
Li Y; Ou X; Hu C
Jpn J Clin Oncol; 2018 Oct; 48(10):927-933. PubMed ID: 30113640
[TBL] [Abstract][Full Text] [Related]
36. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
[TBL] [Abstract][Full Text] [Related]
37. A new T classification based on masticator space involvement in nasopharyngeal carcinoma: a study of 742 cases with magnetic resonance imaging.
Luo DH; Yang J; Qiu HZ; Shen T; Chen QY; Huang PY; Sun R; Qian CN; Mai HQ; Guo X; Mo HY
BMC Cancer; 2014 Sep; 14():653. PubMed ID: 25189623
[TBL] [Abstract][Full Text] [Related]
38. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
Chen Y; Hu XF; Wang Y; Chen HY; Yang L; Liu LZ; Cui CY; Liu DS; Liang SB
BMC Cancer; 2015 Apr; 15():305. PubMed ID: 25903652
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of subclassification using MRI in the t4 classification nasopharyngeal carcinoma intensity-modulated radiotherapy treatment.
Chen L; Liu LZ; Chen M; Li WF; Yin WJ; Lin AH; Sun Y; Li L; Ma J
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):196-202. PubMed ID: 22300569
[TBL] [Abstract][Full Text] [Related]
40. Propensity score matching analysis of cisplatin-based concurrent chemotherapy in low risk nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
Zhang LN; Gao YH; Lan XW; Tang J; Su Z; Ma J; Deng W; OuYang PY; Xie FY
Oncotarget; 2015 Dec; 6(41):44019-29. PubMed ID: 26528755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
